Tempest Therapeutics, Inc.
TPST
$3.03
-$0.03-0.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.74% | 17.76% | -37.40% | -84.47% | -55.56% |
| Total Depreciation and Amortization | -31.96% | -56.77% | -22.73% | -42.35% | 10.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.19% | -18.84% | -6.26% | 4.39% | 58.97% |
| Change in Net Operating Assets | -169.82% | -193.43% | 190.55% | 675.80% | -66.10% |
| Cash from Operations | 33.42% | -53.01% | -11.83% | -64.36% | -56.96% |
| Capital Expenditure | -- | -- | -- | 57.14% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 57.14% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -99.65% | -21.66% | 228.22% | -41.33% | 17,709.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.16% | -73.67% | -260.22% | -47.74% | 7,238.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.83% | -501.58% | -26.84% | -72.31% | -33.87% |